{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:24:20Z","timestamp":1787145860378,"version":"build-2736575974"},"reference-count":424,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002829"],"award-info":[{"award-number":["BX002829"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS), characterized by sustained neuroinflammation, oxidative stress, demyelination, and progressive neurodegeneration. Although MS remains incurable, current disease-modifying therapies (DMTs) help reduce relapse frequency and delay disease progression. Recently developed injectable and infusion-based biologic DMTs offer targeted immunomodulation, but their clinical utility is limited by parenteral administration and the potential for immunogenicity. In contrast, small-molecule DMTs such as fingolimod and teriflunomide provide greater dosing convenience and flexibility; however, their broad immunosuppressive effects often lead to treatment-induced lymphopenia and increased susceptibility to infections. These limitations underscore the need for small-molecule DMTs that achieve selective immunomodulation without compromising systemic immune competence. S-nitrosoglutathione (GSNO), an endogenous nitric oxide (NO\u2022) carrier molecule, has recently emerged as a promising candidate for immunomodulation. GSNO also mitigates oxidative stress, preserves blood-brain barrier integrity, and suppresses neuroinflammatory signaling via S-nitrosylation of key transcription factors such as Nrf2, HIF-1\u03b1, NF-\u03baB, and STATs. The therapeutic potential of GSNO in MS is further supported by the development of reversible GSNO reductase (GSNOR) inhibitors, which elevate endogenous GSNO levels. These inhibitors have demonstrated favorable safety profiles in clinical trials for asthma and cystic fibrosis. In preclinical models of MS, GSNOR inhibitors suppress pathogenic Th1 and Th17 cells and IL-6-producing effector B cells while promoting regulatory T- and B-cell populations, thereby providing selective immunomodulation without broad immune suppression. As a result, they significantly reduce inflammation-driven demyelination. Building on this evidence, this review examines the GSNO\/GSNOR axis as an emerging therapeutic target in MS, highlighting its mechanistic roles in selective immune modulation, the regulation of neuroinflammation, and the attenuation of oxidative stress. Furthermore, we discuss the translational potential of reversible GSNOR inhibitors, which have demonstrated favorable safety and tolerability in Phase I\/II studies for asthma and cystic fibrosis, while emphasizing the need for future clinical evaluation of their therapeutic efficacy in MS.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1797609","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:32:17Z","timestamp":1787142737000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunomodulatory and anti-inflammatory potential of S-nitrosoglutathione (GSNO) in multiple sclerosis: a review of mechanisms and therapeutic perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Jeseong","family":"Won","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Medical University of South Carolina","place":["Charleston, SC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina","place":["Charleston, SC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avtar K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Medical University of South Carolina","place":["Charleston, SC, United States"]},{"name":"Pathology and Laboratory Medicine Service, Ralph H. Johnson Veterans Administration Medical Center","place":["Charleston, SC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inderjit","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina","place":["Charleston, SC, United States"]},{"name":"Research Service, Ralph H. Johnson Veterans Administration Medical Center","place":["Charleston, SC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.38.6.990","article-title":"The familial nature of multiple sclerosis: Age-corrected empiric recurrence risks for children and siblings of patients","volume":"38","author":"Sadovnick","year":"1988","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2012.01134.x","article-title":"The genetics of multiple sclerosis: An up-to-date review","volume":"248","author":"Gourraud","year":"2012","journal-title":"Immunol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0b013e3181c5b47f","article-title":"The natural history of primary progressive multiple sclerosis","volume":"73","author":"Koch","year":"2009","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7191080","article-title":"Inflammation and oxidative stress in multiple sclerosis: Consequences for therapy development","volume":"2020","author":"Pegoretti","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953649","article-title":"Antibody-mediated cell depletion therapies in multiple sclerosis","volume":"13","author":"Mariottini","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.106236","article-title":"Real-world infection risk in multiple sclerosis patients on long-term immunomodulatory treatments","volume":"94","author":"Lambert","year":"2025","journal-title":"Mult Scler Relat Disord"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419836571","article-title":"Risks and risk management in modern multiple sclerosis immunotherapeutic treatment","volume":"12","author":"Klotz","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals","volume":"298","author":"Knowles","year":"1994","journal-title":"Biochem J"},{"key":"B10","first-page":"299","article-title":"Role of cgmp-dependent protein kinase in the cardiovascular system","volume":"36","author":"Wang","year":"2005","journal-title":"Sheng Li Ke Xue Jin Zhan"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031139","article-title":"Guanylyl cyclase-cgmp signaling pathway in melanocytes: Differential effects of altered gravity in non-metastatic and metastatic cells","volume":"21","author":"Ivanova","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002907","article-title":"Cgmp-dependent protein kinases and cgmp phosphodiesterases in nitric oxide and cgmp action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacol Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-020-04900-8","article-title":"Hypoxic stress increases nf-\u03bab and inos mrna expression in normal, but not in keratoconus corneal fibroblasts","volume":"259","author":"Stachon","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1994.266.6.E829","article-title":"New insights into the regulation of inducible nitric oxide synthesis","volume":"266","author":"Morris","year":"1994","journal-title":"Am J Physiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90266-6","article-title":"Nitric oxide synthases: Roles, tolls, and controls","volume":"78","author":"Nathan","year":"1994","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199312303292706","article-title":"The l-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/9780470123119.ch8","article-title":"Mammalian nitric oxide synthases","volume":"65","author":"Stuehr","year":"1992","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-010-2733-x","article-title":"Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices","volume":"88","author":"Jones","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5849(98)00092-6","article-title":"Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide","volume":"25","author":"Wink","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2017.02.009","article-title":"No control of mitochondrial function in normal and transformed cells","volume":"1858","author":"Tengan","year":"2017","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2012.02.004","article-title":"Nitric oxide synthase uncoupling: A therapeutic target in cardiovascular diseases","volume":"57","author":"Roe","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev.pharmtox.42.092501.104328","article-title":"The biochemistry and physiology of s-nitrosothiols","volume":"42","author":"Hogg","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.617366","article-title":"Pcysmod: Prediction of multiple cysteine modifications based on deep learning framework","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1569","article-title":"Protein s-nitrosylation: Purview and parameters","volume":"6","author":"Hess","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8090404","article-title":"S-nitrosylation: An emerging paradigm of redox signaling","volume":"8","author":"Fernando","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.23.10480","article-title":"Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells","volume":"88","author":"Pollock","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.2.682","article-title":"Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme","volume":"87","author":"Bredt","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-0-387-30383-3_4","article-title":"Enos and nnos in stroke","volume-title":"Handbook of Neurochemistry and Molecular Neurobiology: Acute Ischemic Injury and Repair in the Nervous System","author":"Huang","year":"2007"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100746200","article-title":"Basal and stimulated protein s-nitrosylation in multiple cell types and tissues","volume":"277","author":"Gow","year":"2002","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(01)00495-0","article-title":"Nitrosylation. The prototypic redox-based signaling mechanism","volume":"106","author":"Stamler","year":"2001","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R111.285742","article-title":"Regulation by s-nitrosylation of protein post-translational modification","volume":"287","author":"Hess","year":"2012","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.molmed.2009.06.007","article-title":"Protein s-nitrosylation in health and disease: A current perspective","volume":"15","author":"Foster","year":"2009","journal-title":"Trends Mol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00086-5","article-title":"The role of glutathione in the transport and catabolism of nitric oxide","volume":"382","author":"Hogg","year":"1996","journal-title":"FEBS Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/bi00036a023","article-title":"Reaction of nitric oxide with the free sulfhydryl group of human serum albumin yields a sulfenic acid and nitrous oxide","volume":"34","author":"DeMaster","year":"1995","journal-title":"Biochemistry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.5.2175","article-title":"Accelerated reaction of nitric oxide with o2 within the hydrophobic interior of biological membranes","volume":"95","author":"Liu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1021\/tx00040a007","article-title":"Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral ph. Insights into the fate and physiological effects of intermediates generated in the no\/o2 reaction","volume":"7","author":"Wink","year":"1994","journal-title":"Chem Res Toxicol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1021\/ja9536680","article-title":"Mechanism of the nitrosation of thiols and amines by oxygenated \u2022no solutions: the nature of the nitrosating intermediates","volume":"118","author":"Goldstein","year":"1996","journal-title":"J Am Chem Soc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-007-0013-x","article-title":"Role of nitric oxide in inflammatory diseases","volume":"15","author":"Sharma","year":"2007","journal-title":"Inflammopharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/cmi.2014.89","article-title":"Nadph oxidases: An overview from structure to innate immunity-associated pathologies","volume":"12","author":"Panday","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.23.10957","article-title":"Endogenous nitrogen oxides and bronchodilator s-nitrosothiols in human airways","volume":"90","author":"Gaston","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1021\/bi992046e","article-title":"An apoptotic model for nitrosative stress","volume":"39","author":"Eu","year":"2000","journal-title":"Biochemistry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400820","article-title":"Nitric oxide as s-nitrosoproteins in rheumatoid arthritis","volume":"40","author":"Hilliquin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.6.3264","article-title":"A new pathway of nitric oxide\/cyclic gmp signaling involving s-nitrosoglutathione","volume":"273","author":"Mayer","year":"1998","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/10409238.2017.1304353","article-title":"The role of s-nitrosoglutathione reductase (gsnor) in human disease and therapy","volume":"52","author":"Barnett","year":"2017","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/plants8020048","article-title":"S-nitrosoglutathione reductase-the master regulator of protein s-nitrosation in plant no signaling","volume":"8","author":"Jahnov\u00e1","year":"2019","journal-title":"Plants (Basel)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014007","article-title":"Gender differences in s-nitrosoglutathione reductase activity in the lung","volume":"5","author":"Brown-Steinke","year":"2010","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/35068596","article-title":"A metabolic enzyme for s-nitrosothiol conserved from bacteria to humans","volume":"410","author":"Liu","year":"2001","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bbagen.2011.08.012","article-title":"The role of thioredoxin in the regulation of cellular processes by s-nitrosylation","volume":"1820","author":"Sengupta","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200901-0158OC","article-title":"S-nitrosoglutathione reductase: An important regulator in human asthma","volume":"180","author":"Que","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(99)70101-0","article-title":"Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function","volume":"135","author":"Grasemann","year":"1999","journal-title":"J Pediatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.niox.2024.11.005","article-title":"Enhancing S-nitrosoglutathione reductase decreases S-nitrosylation of Ero1\u03b1 and reduces neuronal death in secondary traumatic brain injury","volume":"154","author":"Liu","year":"2025","journal-title":"Nitric Oxide"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1304697","article-title":"Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice","volume":"14","author":"Kim","year":"2023","journal-title":"Front Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.11.025","article-title":"The role of S-nitrosoglutathione reductase (GSNOR) in T cell-mediated immunopathology of experimental autoimmune encephalomyelitis (EAE)","volume":"564","author":"Singh","year":"2025","journal-title":"Neuroscience"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1021\/bi201785u","article-title":"Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase","volume":"51","author":"Green","year":"2012","journal-title":"Biochemistry"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2017.01.009","article-title":"Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508del-CFTR","volume":"16","author":"Donaldson","year":"2017","journal-title":"J Cyst Fibros"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.32.19180","article-title":"S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide","volume":"271","author":"Nikitovic","year":"1996","journal-title":"J Biol Chem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2003.08.022","article-title":"Bilirubin and S-nitrosothiols interaction: Evidence for a possible role of bilirubin as a scavenger of nitric oxide","volume":"66","author":"Mancuso","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041230304","article-title":"Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture","volume":"123","author":"Cocks","year":"1985","journal-title":"J Cell Physiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/308645a0","article-title":"The nature of endothelium-derived vascular relaxant factor","volume":"308","author":"Griffith","year":"1984","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/niox.1996.0112","article-title":"A tutorial on the diffusibility and reactivity of free nitric oxide","volume":"1","author":"Lancaster","year":"1997","journal-title":"Nitric Oxide"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.17.8137","article-title":"Simulation of the diffusion and reaction of endogenously produced nitric oxide","volume":"91","author":"Lancaster","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.02.004","article-title":"S-nitrosoglutathione","volume":"1830","author":"Broniowska","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.redox.2016.05.002","article-title":"Direct measurement of actual levels of nitric oxide (NO) in cell culture conditions using soluble NO donors","volume":"9","author":"He","year":"2016","journal-title":"Redox Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1203\/00006450-200204000-00002","article-title":"S-nitrosoglutathione (GSNO) mediates brain response to hypoxia","volume":"51","author":"Chiueh","year":"2002","journal-title":"Pediatr Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.4590","article-title":"The chemical biology of S-nitrosothiols","volume":"17","author":"Broniowska","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1124\/mi.3.5.253","article-title":"S-nitrosylation signaling in cell biology","volume":"3","author":"Gaston","year":"2003","journal-title":"Mol Interv"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: Mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.37.7.1097","article-title":"Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system","volume":"37","author":"Panitch","year":"1987","journal-title":"Neurology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8128-x","article-title":"Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: Results from a randomized, proof-of-concept study","volume":"263","author":"Havrdov\u00e1","year":"2016","journal-title":"J Neurol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020482","article-title":"T helper cells: The modulators of inflammation in multiple sclerosis","volume":"9","author":"Kunkl","year":"2020","journal-title":"Cells"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00492","article-title":"Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"6","author":"Arellano","year":"2015","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1172\/jci31254","article-title":"A little stress is good: IFN-gamma, demyelination, and multiple sclerosis","volume":"117","author":"Lees","year":"2007","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12974-023-02917-4","article-title":"Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1","volume":"20","author":"Smith","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.10.015","article-title":"Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation","volume":"35","author":"Peters","year":"2011","journal-title":"Immunity"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252464599","article-title":"Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP","volume":"99","author":"Niedbala","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-009-9187-x","article-title":"S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis","volume":"5","author":"Nath","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.freeradbiomed.2018.04.558","article-title":"S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis","volume":"121","author":"Saxena","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K","article-title":"Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages","volume":"28","author":"Huang","year":"1998","journal-title":"Eur J Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313416200","article-title":"Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells","volume":"279","author":"Xiong","year":"2004","journal-title":"J Biol Chem"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/375408a0","article-title":"Altered immune responses in mice lacking inducible nitric oxide synthase","volume":"375","author":"Wei","year":"1995","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.1.308","article-title":"Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase","volume":"160","author":"McInnes","year":"1998","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-79-4-825","article-title":"Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses","volume":"79","author":"MacLean","year":"1998","journal-title":"J Gen Virol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.11.004","article-title":"Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: Evidence from EAE in iNOS KO mice","volume":"160","author":"Dalton","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122494","article-title":"T cell\u2013derived inducible nitric oxide synthase switches off Th17 cell differentiation","volume":"210","author":"Jianjun","year":"2013","journal-title":"J Exp Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1100667108","article-title":"Regulation of type 17 helper T-cell function by nitric oxide during inflammation","volume":"108","author":"Niedbala","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5223","article-title":"STAT3 regulation by S-nitrosylation: Implication for inflammatory disease","volume":"20","author":"Kim","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000191538.76771.66","article-title":"Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells","volume":"97","author":"Saura","year":"2005","journal-title":"Circ Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12169","article-title":"Regulatory T cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol Rev"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200839073","article-title":"Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg","volume":"39","author":"Stephens","year":"2009","journal-title":"Eur J Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017988","article-title":"Intracerebral human regulatory T cells: Analysis of CD4+ CD25+ Foxp3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients","volume":"6","author":"Fritzsching","year":"2011","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.09.006","article-title":"Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals","volume":"251","author":"Fritzsching","year":"2006","journal-title":"J Neurol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple sclerosis and regulatory T cells","volume":"28","author":"Costantino","year":"2008","journal-title":"J ClinImmunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00152","article-title":"Generation and function of induced regulatory T cells","volume":"4","author":"Schmitt","year":"2013","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/39614","article-title":"A Cd4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1211","article-title":"Differentiation of Tr1 cells by immature dendritic cells requires Il-10 but not Cd25+Cd4+ Tr cells","volume":"105","author":"Levings","year":"2005","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/s1286-4579(01)01456-3","article-title":"Oral tolerance: immune mechanisms and the generation of Th3-type Tgf-beta-secreting regulatory cells","volume":"3","author":"Weiner","year":"2001","journal-title":"Microbes Infect"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100485","article-title":"Nitric oxide modulates Tgf-beta-directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development","volume":"186","author":"Lee","year":"2011","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804394","article-title":"Myelin basic protein priming reduces the expression of Foxp3 in T cells via nitric oxide","volume":"184","author":"Brahmachari","year":"2010","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0703725104","article-title":"Nitric oxide induces Cd4+Cd25+ Foxp3 regulatory T cells from Cd4+Cd25 T cells via P53, Il-2, and Ox40","volume":"104","author":"Niedbala","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B107","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1568007053005091","article-title":"Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents","volume":"4","author":"Langley","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401769","article-title":"Hats and Hdacs in neurodegeneration: a tale of disconcerted acetylation homeostasis","volume":"13","author":"Saha","year":"2006","journal-title":"Cell Death Differ"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2358","article-title":"Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary","volume":"7","author":"Lopez-Diego","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-06-2903","article-title":"Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity","volume":"13","author":"Nencioni","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1172\/jci34712","article-title":"Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent Dc functions and regulates experimental graft-versus-host disease in mice","volume":"118","author":"Reddy","year":"2008","journal-title":"J Clin Invest"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0708401","article-title":"Blocking Th17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo","volume":"84","author":"Bosisio","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molmed.2009.12.003","article-title":"Disturbed regulatory T cell homeostasis in multiple sclerosis","volume":"16","author":"Venken","year":"2010","journal-title":"Trends Mol Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: Cd4+Cd25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh029","article-title":"Il-10 is involved in the suppression of experimental autoimmune encephalomyelitis by Cd25+Cd4+ regulatory T cells","volume":"16","author":"Zhang","year":"2004","journal-title":"Int Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3031","article-title":"Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of Foxp3+ regulatory T cells","volume":"8","author":"Wang","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/nm1652","article-title":"Deacetylase inhibition promotes the generation and function of regulatory T cells","volume":"13","author":"Tao","year":"2007","journal-title":"Nat Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.04.018","article-title":"Histone\/protein deacetylase inhibitors increase suppressive functions of human Foxp3+ Tregs","volume":"136","author":"Akimova","year":"2010","journal-title":"Clin Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-207118","article-title":"Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization","volume":"115","author":"van Loosdregt","year":"2010","journal-title":"Blood"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3874","article-title":"Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in Sjl\/J mice at multiple steps","volume":"170","author":"Dasgupta","year":"2003","journal-title":"J Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2005.02.022","article-title":"Transcriptional therapy with the histone deacetylase inhibitor trichostatin a ameliorates experimental autoimmune encephalomyelitis","volume":"164","author":"Camelo","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3109\/08830180903349669","article-title":"Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege","volume":"29","author":"Huang","year":"2010","journal-title":"Int Rev Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1182\/blood-2005-01-0122","article-title":"Dendritic cells have the option to express Ido-mediated suppression or not","volume":"105","author":"Munn","year":"2005","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0737363100","article-title":"Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway","volume":"100","author":"Ryu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0907935106","article-title":"Hdac6 is a target for protection and regeneration following injury in the nervous system","volume":"106","author":"Rivieccio","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0803749105","article-title":"Hdac6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation","volume":"105","author":"Parmigiani","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1218126110","article-title":"S-nitrosylation of Hdac2 regulates the expression of the chromatin-remodeling factor Brm during radial neuron migration","volume":"110","author":"Nott","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805514105","article-title":"Hdac2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment","volume":"105","author":"Colussi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b15-00364","article-title":"Regulation of histone deacetylase 6 activity via S-nitrosylation","volume":"38","author":"Okuda","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005375","article-title":"Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase Sirt1 to increase acetylation and activation of P53 and P65","volume":"7","author":"Shinozaki","year":"2014","journal-title":"Sci Signal"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102053","article-title":"Regulation of B cell functions by S-nitrosoglutathione in the Eae model","volume":"45","author":"Kim","year":"2021","journal-title":"Redox Biol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2018.06.003","article-title":"Regulation of Il-10 and Il-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione","volume":"223","author":"Singh","year":"2018","journal-title":"Immunobiology"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.6064\/2012\/215308","article-title":"B cell in autoimmune diseases","volume":"2012","author":"Hampe","year":"2012","journal-title":"Scientifica (Cairo)"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2018.11.008","article-title":"Regulatory and effector B cells: friends or foes","volume":"93","author":"Matsushita","year":"2019","journal-title":"J Dermatol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of Il-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J Exp Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130699","article-title":"Mhc class Ii-dependent B cell Apc function is required for induction of Cns autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J Exp Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10100758","article-title":"Anti-Cd20 agents for multiple sclerosis: spotlight on ocrelizumab and ofatumumab","volume":"10","author":"Florou","year":"2020","journal-title":"Brain Sci"},{"key":"B140","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/dddt.S41645","article-title":"Rituximab for the treatment of rheumatoid arthritis: an update","volume":"8","author":"Mok","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1611778","article-title":"Cd20 monoclonal antibodies for the treatment of multiple sclerosis: up-to-date","volume":"19","author":"Ancau","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase Ii\/Iii systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20215","article-title":"Exacerbation of ulcerative colitis after rituximab salvage therapy","volume":"13","author":"Goetz","year":"2007","journal-title":"Inflammation Bowel Dis"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/art.22811","article-title":"Development of psoriasis after B cell depletion with rituximab","volume":"56","author":"Dass","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B145","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clim.2017.04.014","article-title":"Effector and regulatory B cells in multiple sclerosis","volume":"184","author":"Staun-Ram","year":"2017","journal-title":"Clin Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s13317-018-0109-x","article-title":"Regulatory B and T lymphocytes in multiple sclerosis: friends or foes","volume":"9","author":"Vasileiadis","year":"2018","journal-title":"Auto Immun Highlights"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare Il-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"Cd19(+)Cd24(Hi)Cd38(Hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B149","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar3907","article-title":"Il-10-producing regulatory B cells (B10 cells) in autoimmune disease","volume":"15","author":"Kalampokis","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36030","article-title":"Regulatory B cells inhibit Eae initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803052","article-title":"Selective targeting of B cells with agonistic anti-cd40 is an efficacious strategy for the generation of induced regulatory t2-like B cells and for the suppression of lupus in mrl\/lpr mice","volume":"182","author":"Blair","year":"2009","journal-title":"J Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.08.010","article-title":"Regulatory B cells in skin and connective tissue diseases","volume":"60","author":"Fujimoto","year":"2010","journal-title":"J Dermatol Sci"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1319","article-title":"A novel splenic b1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-akt pathway activation","volume":"138","author":"Matsushita","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J Exp Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of il-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2009.11.009","article-title":"B1 cells produce nitric oxide in response to a series of toll-like receptor ligands","volume":"261","author":"Tumurkhuu","year":"2010","journal-title":"Cell Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/ni1001-907","article-title":"Nitric oxide and the immune response","volume":"2","author":"Bogdan","year":"2001","journal-title":"Nat Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.82131-0","article-title":"Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice","volume":"87","author":"Jayasekera","year":"2006","journal-title":"J Gen Virol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/nature06033","article-title":"Regulation of iga production by naturally occurring tnf\/inos-producing dendritic cells","volume":"448","author":"Tezuka","year":"2007","journal-title":"Nature"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90005-1","article-title":"Nitric oxide produced by human B lymphocytes inhibits apoptosis and epstein-barr virus reactivation","volume":"79","author":"Mannick","year":"1994","journal-title":"Cell"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2806","article-title":"Inducible nitric oxide synthase is a major intermediate in signaling pathways for the survival of plasma cells","volume":"15","author":"Saini","year":"2014","journal-title":"Nat Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7672","article-title":"Nitric oxide reversibly inhibits seven members of the caspase family via s-nitrosylation","volume":"240","author":"Li","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578673","article-title":"Therapeutic potential of s-nitrosoglutathione reductase inhibitor in B cell-driven experimental autoimmune encephalomyelitis","volume":"406","author":"Won","year":"2025","journal-title":"J Neuroimmunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2010.12.010","article-title":"Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease","volume":"25","author":"Olson","year":"2011","journal-title":"Nitric Oxide"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an o2-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1172\/jci29444","article-title":"S-nitrosothiols signal hypoxia-mimetic vascular pathology","volume":"117","author":"Palmer","year":"2007","journal-title":"J Clin Invest"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify hif","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von hippel-lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J Biol Chem"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.190332597","article-title":"Activation of hif1alpha ubiquitination by a reconstituted von hippel-lindau (vhl) tumor suppressor complex","volume":"97","author":"Kamura","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.67","article-title":"Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory t cells in murine colitis","volume":"9","author":"Fl\u00fcck","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/stem.3250","article-title":"Allogeneic adipose-derived stem cells promote ischemic muscle repair by inducing m2 macrophage polarization via the hif-1\u03b1\/il-10 pathway","volume":"38","author":"Liu","year":"2020","journal-title":"Stem Cells"},{"key":"B172","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41467-017-02683-x","article-title":"Hypoxia-inducible factor-1alpha is a critical transcription factor for il-10-producing B cells in autoimmune disease","volume":"9","author":"Meng","year":"2018","journal-title":"Nat Commun"},{"key":"B173","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molcel.2007.02.024","article-title":"Regulation of hif-1alpha stability through s-nitrosylation","volume":"26","author":"Li","year":"2007","journal-title":"Mol Cell"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e02-12-0791","article-title":"Nitric oxide impairs normoxic degradation of hif-1alpha by inhibition of prolyl hydroxylases","volume":"14","author":"Metzen","year":"2003","journal-title":"Mol Biol Cell"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2011.04.075","article-title":"Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (egln1)","volume":"410","author":"Chowdhury","year":"2011","journal-title":"J Mol Biol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/ni1357","article-title":"Transcription factor irf4 controls plasma cell differentiation and class-switch recombination","volume":"7","author":"Klein","year":"2006","journal-title":"Nat Immunol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5299.540","article-title":"Requirement for the transcription factor lsirf\/irf4 for mature B and T lymphocyte function","volume":"275","author":"Mittr\u00fccker","year":"1997","journal-title":"Science"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.07.009","article-title":"Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation","volume":"25","author":"Sciammas","year":"2006","journal-title":"Immunity"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131026","article-title":"Irf4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating notch2 expression and activity","volume":"210","author":"Simonetti","year":"2013","journal-title":"J Exp Med"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"B181","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/eji.201646549","article-title":"Il-10 production in murine igm(+) cd138(hi) cells is driven by blimp-1 and downregulated in class-switched cells","volume":"47","author":"Suzuki-Yamazaki","year":"2017","journal-title":"Eur J Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003858","article-title":"Murine gammaherpesvirus m2 protein induction of irf4 via the nfat pathway leads to il-10 expression in B cells","volume":"10","author":"Rangaswamy","year":"2014","journal-title":"PloS Pathog"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33227","article-title":"The transcription factor ifn regulatory factor-4 controls experimental colitis in mice via t cell-derived il-6","volume":"118","author":"Mudter","year":"2008","journal-title":"J Clin Invest"},{"key":"B184","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1038\/ncomms5575","article-title":"Nitric oxide enhances th9 cell differentiation and airway inflammation","volume":"5","author":"Niedbala","year":"2014","journal-title":"Nat Commun"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00446-2","article-title":"Transcriptional regulation of memory B cell differentiation","volume":"21","author":"Laidlaw","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1103503108","article-title":"On-off system for pi3-kinase-akt signaling through s-nitrosylation of phosphatase with sequence homology to tensin (pten)","volume":"108","author":"Numajiri","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.059782","article-title":"S-nitrosylation at cysteine 498 of c-src tyrosine kinase regulates nitric oxide-mediated cell invasion","volume":"285","author":"Rahman","year":"2010","journal-title":"J Biol Chem"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01435-13","article-title":"Interferon regulatory factor 4 is activated through c-src-mediated tyrosine phosphorylation in virus-transformed cells","volume":"87","author":"Wang","year":"2013","journal-title":"J Virol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.07.006","article-title":"Contribution of cd8 t lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models","volume":"1812","author":"Mars","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02771.x","article-title":"Generation of no by bystander human cd8 t cells augments allogeneic responses by inhibiting cytokine deprivation-induced cell death","volume":"9","author":"Choy","year":"2009","journal-title":"Am J Transplant"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-22-0387","article-title":"Infiltration of tumors is regulated by t cell-intrinsic nitric oxide synthesis","volume":"11","author":"Cunha","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.058446","article-title":"Role of nitric oxide in the regulation of t cell functions","author":"Niedbala","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00606","article-title":"Regulatory functions of natural killer cells in multiple sclerosis","volume":"7","author":"Gross","year":"2016","journal-title":"Front Immunol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.869447","article-title":"Natural killer cells in multiple sclerosis: entering the stage","volume":"13","author":"Beli\u00ebn","year":"2022","journal-title":"Front Immunol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the cd56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"B196","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jaut.2016.04.003","article-title":"Dysregulation of regulatory cd56(bright) nk cells\/t cells interactions in multiple sclerosis","volume":"72","author":"Laroni","year":"2016","journal-title":"J Autoimmun"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092749","article-title":"Central nervous system (cns)-resident natural killer cells suppress th17 responses and cns autoimmune pathology","volume":"207","author":"Hao","year":"2010","journal-title":"J Exp Med"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front Immunol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31533","article-title":"The ratio of circulating cd56(dim) nk cells to follicular t helper cells as a promising predictor for disease activity of relapsing-remitting multiple sclerosis","volume":"10","author":"Ding","year":"2024","journal-title":"Heliyon"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2000.2.4-673","article-title":"Nitric oxide induces a decrease in the mitochondrial membrane potential of peripheral blood lymphocytes, especially in natural killer cells","volume":"2","author":"Takabayashi","year":"2000","journal-title":"Antioxid Redox Signal"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.781","article-title":"The Cd16-\/Cd56bright subset of Nk cells is resistant to oxidant-induced cell death","volume":"179","author":"Thor\u00e9n","year":"2007","journal-title":"J Immunol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/cs20140608","article-title":"T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis","volume":"129","author":"Ruocco","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812530106","article-title":"Il-9 induces differentiation of Th17 cells and enhances function of Foxp3+ natural regulatory T cells","volume":"106","author":"Elyaman","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01120","article-title":"Atp triggers human Th9 cell differentiation via nitric oxide-mediated mtor-hif1\u03b1 pathway","volume":"10","author":"Roy","year":"2019","journal-title":"Front Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s1474-4422(23)00377-0","article-title":"Blood-brain barrier dysfunction in multiple sclerosis: Causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000001586","article-title":"Meningeal inflammation in multiple sclerosis: The key to the origin of cortical lesions","volume":"85","author":"Mainero","year":"2015","journal-title":"Neurology"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/948976","article-title":"The benefits and detriments of macrophages\/microglia in models of multiple sclerosis","volume":"2013","author":"Rawji","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: The good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J Neuroinflamm"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1172\/jci119473","article-title":"Perspectives series: Host\/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity","volume":"99","author":"Fang","year":"1997","journal-title":"J Clin Invest"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood-brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult Scler"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/113.5.1477","article-title":"Breakdown of the blood-brain barrier precedes symptoms and other mri signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications","volume":"113","author":"Kermode","year":"1990","journal-title":"Brain"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med"},{"key":"B213","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12576-022-00857-x","article-title":"Critical role of Rho proteins in myosin light chain di-phosphorylation during early phase of endothelial barrier disruption","volume":"72","author":"Hirano","year":"2022","journal-title":"J Physiol Sci"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10523","article-title":"Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury","volume":"7","author":"Shi","year":"2016","journal-title":"Nat Commun"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1159\/000330247","article-title":"Neuroinflammation: A common pathway in cns diseases as mediated at the blood-brain barrier","volume":"19","author":"Erickson","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/s1537-1891(03)00008-9","article-title":"Rho gtpases and the regulation of endothelial permeability","volume":"39","author":"Wojciak-Stothard","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.115972","article-title":"Enos-derived nitric oxide regulates endothelial barrier function through ve-cadherin and rho gtpases","volume":"126","author":"Di Lorenzo","year":"2013","journal-title":"J Cell Sci"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.547596","article-title":"Lipopolysaccharide-induced lung injury involves the nitration-mediated activation of Rhoa","volume":"289","author":"Rafikov","year":"2014","journal-title":"J Biol Chem"},{"key":"B219","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.niox.2018.12.007","article-title":"Regulation of endothelial barrier integrity by redox-dependent nitric oxide signaling: Implication in traumatic and inflammatory brain injuries","volume":"83","author":"Choi","year":"2019","journal-title":"Nitric Oxide"},{"key":"B220","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.niox.2018.01.007","article-title":"Rhoa inactivation by S-nitrosylation regulates vascular smooth muscle contractive signaling","volume":"74","author":"Lin","year":"2018","journal-title":"Nitric Oxide"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.87.4.335","article-title":"Activation of Rhoa by thrombin in endothelial hyperpermeability: Role of rho kinase and protein tyrosine kinases","volume":"87","author":"van Nieuw Amerongen","year":"2000","journal-title":"Circ Res"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/s0031-6997(24)01493-5","article-title":"Proteinase-activated receptors","volume":"53","author":"Macfarlane","year":"2001","journal-title":"Pharmacol Rev"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4547(19980215)51:4<423::Aid-jnr2>3.0.Co;2-e","article-title":"Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease","volume":"51","author":"Andjelkovic","year":"1998","journal-title":"J Neurosci Res"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-4310(97)01066-6","article-title":"The role of adhesion molecules in multiple sclerosis: Biology, pathogenesis and therapeutic implications","volume":"3","author":"Archelos","year":"1997","journal-title":"Mol Med Today"},{"key":"B225","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0165-5728(99)00084-3","article-title":"Adhesion molecule expression and regulation on cells of the central nervous system","volume":"98","author":"Lee","year":"1999","journal-title":"J Neuroimmunol"},{"key":"B226","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ana.410350114","article-title":"Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis","volume":"35","author":"Washington","year":"1994","journal-title":"Ann Neurol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90239-9","article-title":"Expression of Icam-1, Vcam-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis","volume":"54","author":"Dopp","year":"1994","journal-title":"J Neuroimmunol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/glia.20436","article-title":"Gsno attenuates eae disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions","volume":"55","author":"Prasad","year":"2007","journal-title":"Glia"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015531","article-title":"Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis","volume":"5","author":"Domingues","year":"2010","journal-title":"PloS One"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4648","article-title":"Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis","volume":"181","author":"Furtado","year":"2008","journal-title":"J Immunol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01175","article-title":"Transcriptional regulation of macrophages polarization by micrornas","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1990","article-title":"Irf5 promotes inflammatory macrophage polarization and Th1-Th17 responses","volume":"12","author":"Krausgruber","year":"2011","journal-title":"Nat Immunol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1615\/critrevimmunol.v32.i6.10","article-title":"M1 and M2 macrophages: Oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J Exp Med"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-35","article-title":"Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status","volume":"10","author":"Vogel","year":"2013","journal-title":"J Neuroinflamm"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.12703\/p6-13","article-title":"The M1 and M2 paradigm of macrophage activation: Time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"Ppargamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metab"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1172\/jci45444","article-title":"Kr\u00fcppel-like factor 4 regulates macrophage polarization","volume":"121","author":"Liao","year":"2011","journal-title":"J Clin Invest"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during cns remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat Neurosci"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: Phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front Immunol"},{"key":"B243","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1038\/ncomms7676","article-title":"Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization","volume":"6","author":"Lu","year":"2015","journal-title":"Nat Commun"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1218599110","article-title":"Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production","volume":"110","author":"Michelucci","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of Keap1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0052-z","article-title":"Electrophilic properties of itaconate and derivatives regulate the i\u03bab\u03b6-atf3 inflammatory axis","volume":"556","author":"Bambouskova","year":"2018","journal-title":"Nature"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02050-1","article-title":"4-octyl itaconate attenuates neuroinflammation in experimental autoimmune encephalomyelitis via regulating microglia","volume":"48","author":"Zhao","year":"2025","journal-title":"Inflammation"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13454","article-title":"Itaconate and fumarate derivatives inhibit priming and activation of the canonical Nlrp3 inflammasome in macrophages","volume":"165","author":"Hoyle","year":"2022","journal-title":"Immunology"},{"key":"B249","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41467-020-14433-7","article-title":"Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase","volume":"11","author":"Palmieri","year":"2020","journal-title":"Nat Commun"},{"key":"B250","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.celrep.2019.06.018","article-title":"Nitric oxide modulates metabolic remodeling in inflammatory macrophages through tca cycle regulation and itaconate accumulation","volume":"28","author":"Bailey","year":"2019","journal-title":"Cell Rep"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-026-01492-1","article-title":"Inos modulates inflammatory responses in an no-independent manner through direct interaction with irg1 in mitochondria","volume":"8","author":"Diotallevi","year":"2026","journal-title":"Nat Metab"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1812704115","article-title":"Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth","volume":"115","author":"Arora","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1021\/pr201180m","article-title":"Proteomic characterization of the cellular response to nitrosative stress mediated by s-nitrosoglutathione reductase inhibition","volume":"11","author":"Foster","year":"2012","journal-title":"J Proteome Res"},{"key":"B254","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of nf-kappab: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00471","article-title":"The role of the transcription factor nuclear factor-kappa b in thyroid autoimmunity and cancer","volume":"9","author":"Giuliani","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000158","article-title":"The ikk complex, a central regulator of nf-kappab activation","volume":"2","author":"Israel","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The ikk nf-kappa b system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01608.x","article-title":"Inhibitory kappa b kinases as targets for pharmacological regulation","volume":"165","author":"Gamble","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-018-0061-4","article-title":"Involvement of inhibitor kappa b kinase 2 (ikk2) in the regulation of vascular tone","volume":"98","author":"Kwon","year":"2018","journal-title":"Lab Invest"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2705","article-title":"Nf-kappa b regulation by i kappa b kinase-2 in rheumatoid arthritis synoviocytes","volume":"166","author":"Aupperle","year":"2001","journal-title":"J Immunol"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.161984","article-title":"Modification of cysteine 179 of ikappabalpha kinase by nimbolide leads to down-regulation of nf-kappab-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents","volume":"285","author":"Gupta","year":"2010","journal-title":"J Biol Chem"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.18.11.1796","article-title":"No inhibits cytokine-induced inos expression and nf-kappab activation by interfering with phosphorylation and degradation of ikappab-alpha","volume":"18","author":"Katsuyama","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600012","article-title":"S-nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke","volume":"25","author":"Khan","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1007\/s002100100435","article-title":"Nitric oxide prevents inducible cyclooxygenase expression by inhibiting nuclear factor-kappa b and nuclear factor-interleukin-6 activation","volume":"364","author":"D'Acquisto","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B265","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s000110050729","article-title":"S-nitrosoglutathione inhibits tnf-alpha-induced nfkappab activation in neutrophils","volume":"50","author":"Fortenberry","year":"2001","journal-title":"Inflammation Res"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705929200","article-title":"Nos2 regulation of nf-kappab by s-nitrosylation of p65","volume":"282","author":"Kelleher","year":"2007","journal-title":"J Biol Chem"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1021\/bi002239y","article-title":"Inhibition of nf-kappa b by s-nitrosylation","volume":"40","author":"Marshall","year":"2001","journal-title":"Biochemistry"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5332.1630","article-title":"Stats and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203527","article-title":"Stats in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0","article-title":"Activation of stat proteins and growth control","volume":"23","author":"Bromberg","year":"2001","journal-title":"Bioessays"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1995.1235","article-title":"Distribution of the mammalian stat gene family in mouse chromosomes","volume":"29","author":"Copeland","year":"1995","journal-title":"Genomics"},{"key":"B273","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type i interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703838","article-title":"Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of stat1 by endogenous nitric oxide","volume":"132","author":"Llovera","year":"2001","journal-title":"Br J Pharmacol"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-121786","article-title":"Protective role of s-nitrosoglutathione (gsno) against cognitive impairment in rat model of chronic cerebral hypoperfusion","volume":"34","author":"Won","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1202117","article-title":"Jaks and stats in immunity, immunodeficiency, and cancer","volume":"368","author":"O'Shea","year":"2013","journal-title":"N Engl J Med"},{"key":"B277","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"Stat3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082299","article-title":"Contribution of stat3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment","volume":"19","author":"Kasembeli","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.02.039","article-title":"Regulation of stat3 and nf-\u03bab activations by s-nitrosylation in multiple myeloma","volume":"106","author":"Kim","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"B280","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.redox.2015.07.001","article-title":"S-nitrosoglutathione-mediated stat3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma","volume":"6","author":"Kaliyaperumal","year":"2015","journal-title":"Redox Biol"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191761","article-title":"Noncanonical stat3 activity sustains pathogenic th17 proliferation and cytokine response to antigen","volume":"217","author":"Poholek","year":"2020","journal-title":"J Exp Med"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8100406","article-title":"Monitoring the redox status in multiple sclerosis","volume":"8","author":"Tanaka","year":"2020","journal-title":"Biomedicines"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160401120514","article-title":"Oxidative stress and antioxidants in neurological diseases: is there still hope","volume":"18","author":"Carvalho","year":"2017","journal-title":"Curr Drug Targets"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13030266","article-title":"Crosstalk between oxidative stress and inflammation caused by noise and air pollution-implications for neurodegenerative diseases","volume":"13","author":"Kunti\u0107","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.072496","article-title":"Nitric-oxide synthase forms n-no-pterin and s-no-cys: implications for activity, allostery, and regulation","volume":"285","author":"Rosenfeld","year":"2010","journal-title":"J Biol Chem"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1021\/bi011877t","article-title":"Control of nitric oxide synthase dimer assembly by a heme-no-dependent mechanism","volume":"41","author":"Chen","year":"2002","journal-title":"Biochemistry"},{"key":"B287","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.niox.2016.10.001","article-title":"Nitrosothiol formation and s-nitrosation signaling through nitric oxide synthases","volume":"63","author":"Wynia-Smith","year":"2017","journal-title":"Nitric Oxide"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5849(01)00489-0","article-title":"Peroxynitrite inhibits inducible (type 2) nitric oxide synthase in murine lung epithelial cells in vitro","volume":"30","author":"Robinson","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"B289","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/bj20020339","article-title":"Inducible nitric oxide synthase (nos2) expressed in septic patients is nitrated on selected tyrosine residues: implications for enzymic activity","volume":"366","author":"Lanone","year":"2002","journal-title":"Biochem J"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M413058200","article-title":"Receptor-regulated dynamic s-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells","volume":"280","author":"Erwin","year":"2005","journal-title":"J Biol Chem"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0300464101","article-title":"S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity","volume":"101","author":"Ravi","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B293","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/dna.2007.0655","article-title":"Identification of the cysteine nitrosylation sites in human endothelial nitric oxide synthase","volume":"27","author":"Tummala","year":"2008","journal-title":"DNA Cell Biol"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407294102","article-title":"S-nitrosylation of hsp90 promotes the inhibition of its atpase and endothelial nitric oxide synthase regulatory activities","volume":"102","author":"Mart\u00ednez-Ruiz","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5066","article-title":"Specificity in s-nitrosylation: a short-range mechanism for no signaling","volume":"19","author":"Mart\u00ednez-Ruiz","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med Res Rev"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-273094","article-title":"The prolyl isomerase pin1 acts as a novel molecular switch for tnf- -induced priming of the nadph oxidase in human neutrophils","volume":"116","author":"Tarek","year":"2010","journal-title":"Blood"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws012","article-title":"Nadph oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain"},{"key":"B299","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The nox family of ros-generating nadph oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2007.03.030","article-title":"Nitric oxide suppresses nadph oxidase-dependent superoxide production by s-nitrosylation in human endothelial cells","volume":"75","author":"Selemidis","year":"2007","journal-title":"Cardiovasc Res"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1179\/1351000215Y.0000000014","article-title":"S-nitrosylation of P47(Phox) enhances phosphorylation by casein kinase 2","volume":"20","author":"Kil","year":"2015","journal-title":"Redox Rep"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2012.01284.x","article-title":"Exogenous nitric oxide negatively regulates the S-nitrosylation p38 mitogen-activated protein kinase activation during cerebral ischaemia and reperfusion","volume":"39","author":"Qi","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.37","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis","volume":"10","author":"Friese","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.213542","article-title":"Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis","volume":"12","author":"Heidker","year":"2017","journal-title":"Neural Regener Res"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(14)70256-x","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol"},{"key":"B306","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.ircmb.2016.08.003","article-title":"Mitochondria in multiple sclerosis: molecular mechanisms of pathogenesis","volume":"328","author":"Patergnani","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1134\/s0006297918070052","article-title":"Involvement of mitochondria in neurodegeneration in multiple sclerosis","volume":"83","author":"Kozin","year":"2018","journal-title":"Biochem (Mosc)"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann Neurol"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(09)70043-2","article-title":"Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis","volume":"8","author":"Trapp","year":"2009","journal-title":"Lancet Neurol"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-1052-y","article-title":"Reduced expression of Pgc-1\u03b1 partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex","volume":"125","author":"Witte","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B311","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2010.00401.x","article-title":"Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis","volume":"20","author":"Dziedzic","year":"2010","journal-title":"Brain Pathol"},{"key":"B312","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.22139","article-title":"Oxidative stress disrupts oligodendrocyte maturation","volume":"87","author":"French","year":"2009","journal-title":"J Neurosci Res"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2009.12.141","article-title":"Oligodendroglial differentiation induces mitochondrial genes and inhibition of mitochondrial function represses oligodendroglial differentiation","volume":"10","author":"Schoenfeld","year":"2010","journal-title":"Mitochondrion"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22109","article-title":"Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis","volume":"69","author":"Campbell","year":"2011","journal-title":"Ann Neurol"},{"key":"B315","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/path.2582","article-title":"Enhanced number and activity of mitochondria in multiple sclerosis lesions","volume":"219","author":"Witte","year":"2009","journal-title":"J Pathol"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R117.789271","article-title":"Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions","volume":"292","author":"Wong","year":"2017","journal-title":"J Biol Chem"},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07814.x","article-title":"Fundamental aspects of reactive oxygen species, or what's the matter with oxygen","volume":"893","author":"Fridovich","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705430","article-title":"On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies","volume":"140","author":"Muscoli","year":"2003","journal-title":"Br J Pharmacol"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7631","article-title":"Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione","volume":"95","author":"Clementi","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B320","doi-asserted-by":"publisher","DOI":"10.1042\/0264-6021:3590139","article-title":"Nitric oxide inhibits mitochondrial Nadh:ubiquinone reductase activity through peroxynitrite formation","volume":"359","author":"Riob\u00f3","year":"2001","journal-title":"Biochem J"},{"key":"B321","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mam.2004.02.005","article-title":"Mitochondrial free radical production and cell signaling","volume":"25","author":"Cadenas","year":"2004","journal-title":"Mol Aspects Med"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(94)01290-3","article-title":"Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase","volume":"356","author":"Brown","year":"1994","journal-title":"FEBS Lett"},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(94)00424-2","article-title":"Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases","volume":"345","author":"Cleeter","year":"1994","journal-title":"FEBS Lett"},{"key":"B324","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.108.181628","article-title":"Nitric oxide, cytochrome c oxidase, and the cellular response to hypoxia","volume":"30","author":"Taylor","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B325","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0891-5849(02)01298-4","article-title":"Characterization and function of mitochondrial nitric-oxide synthase","volume":"34","author":"Giulivi","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.02.005","article-title":"Mitochondrial nitric oxide synthase","volume":"26","author":"Ghafourifar","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R113.472936","article-title":"Peroxynitrite, a stealthy biological oxidant","volume":"288","author":"Radi","year":"2013","journal-title":"J Biol Chem"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2024.0099","article-title":"The role of protein S-nitrosylation in mitochondrial quality control in central nervous system diseases","volume":"16","author":"Qiu","year":"2024","journal-title":"Aging Dis"},{"key":"B329","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/0264-6021:3560395","article-title":"Metabolism of S-nitrosoglutathione in intact mitochondria","volume":"356","author":"Steffen","year":"2001","journal-title":"Biochem J"},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-011-9352-9","article-title":"Different effects of Snp and Gsno on mitochondrial O2 .- \/H 2o2 production","volume":"43","author":"Tessari","year":"2011","journal-title":"J Bioenerg Biomembr"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3212","article-title":"Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I","volume":"19","author":"Chouchani","year":"2013","journal-title":"Nat Med"},{"key":"B332","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M509507200","article-title":"Nitric oxide inhibits peroxidase activity of cytochrome c.cardiolipin complex and blocks cardiolipin oxidation","volume":"281","author":"Vlasova","year":"2006","journal-title":"J Biol Chem"},{"key":"B333","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M512203200","article-title":"Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria","volume":"281","author":"Dahm","year":"2006","journal-title":"J Biol Chem"},{"key":"B334","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1021\/tx400462r","article-title":"Respiratory substrates regulate S-nitrosylation of mitochondrial proteins through a thiol-dependent pathway","volume":"27","author":"Chang","year":"2014","journal-title":"Chem Res Toxicol"},{"key":"B335","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201708007","article-title":"Superoxide dismutases: dual roles in controlling Ros damage and regulating Ros signaling","volume":"217","author":"Wang","year":"2018","journal-title":"J Cell Biol"},{"key":"B336","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-99866-6.00009-X","article-title":"Chapter 16 - Advance oxidation processes for remediation of antibiotics from wastewater","volume-title":"Degradation of Antibiotics and Antibiotic-Resistant Bacteria From Various Sources","author":"Prakash","year":"2023"},{"key":"B337","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.010909.105600","article-title":"Mechanisms of cell protection by heme oxygenase-1","volume":"50","author":"Gozzelino","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B338","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00061","article-title":"Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes","volume":"5","author":"Chiabrando","year":"2014","journal-title":"Front Pharmacol"},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.47275\/2332-4864-118","article-title":"Morphometric effects of Ho-1 deficiency and overexpression in rat glomeruli and podocytes","volume":"6","author":"Wilson","year":"2021","journal-title":"J Clin Anat Pathol (JCAP)"},{"key":"B340","doi-asserted-by":"publisher","DOI":"10.1007\/s10482-011-9550-9","article-title":"Glutathione peroxidase3 of Saccharomyces cerevisiae protects phospholipids during cadmium-induced oxidative stress","volume":"99","author":"Muthukumar","year":"2011","journal-title":"Antonie van Leeuwenhoek"},{"key":"B341","doi-asserted-by":"publisher","DOI":"10.1042\/bst0150717","article-title":"The enzymes of glutathione metabolism: an overview","volume":"15","author":"Mannervik","year":"1987","journal-title":"Biochem Soc Trans"},{"key":"B342","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081244","article-title":"Peroxiredoxins as potential targets for cardiovascular disease","volume":"10","author":"Jeong","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B343","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1323.002","article-title":"The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process","volume":"1055","author":"Yoshida","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B344","doi-asserted-by":"publisher","first-page":"12761","DOI":"10.1038\/s41598-022-16840-w","article-title":"Expression of antioxidant enzymes in lesions of multiple sclerosis and its models","volume":"12","author":"Moezzi","year":"2022","journal-title":"Sci Rep"},{"key":"B345","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111579","article-title":"Acrolein: a potential mediator of oxidative damage in diabetic retinopathy","volume":"10","author":"Alfarhan","year":"2020","journal-title":"Biomolecules"},{"key":"B346","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s42003-021-02988-0","article-title":"Gsnor regulates ganoderic acid content in Ganoderma lucidum under heat stress through S-nitrosylation of catalase","volume":"5","author":"Liu","year":"2022","journal-title":"Commun Biol"},{"key":"B347","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01180-8","article-title":"Hypoxia, oxidative stress, and the interplay of Hifs and Nrf2 signaling in cancer","volume":"56","author":"Bae","year":"2024","journal-title":"Exp Mol Med"},{"key":"B348","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev"},{"key":"B349","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.01704-07","article-title":"Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity","volume":"28","author":"Yamamoto","year":"2008","journal-title":"Mol Cell Biol"},{"key":"B350","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2009.06.016","article-title":"Cysteine-based regulation of the Cul3 adaptor protein Keap1","volume":"244","author":"Sekhar","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"B351","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/Small Maf heterodimer mediates the induction of phase ii detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"B352","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/bst0280033","article-title":"The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin","volume":"28","author":"Hayes","year":"2000","journal-title":"Biochem Soc Trans"},{"key":"B353","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.redox.2015.12.005","article-title":"The novel triterpenoid Rta 408 protects human retinal pigment epithelial cells against H2o2-induced cell injury via Nf-E2-related factor 2 (Nrf2) activation","volume":"8","author":"Liu","year":"2016","journal-title":"Redox Biol"},{"key":"B354","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B355","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.25.14960","article-title":"Nrf1 and Nrf2 positively and C-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of Nad(P)H:quinone oxidoreductase1 gene","volume":"93","author":"Venugopal","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B356","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","article-title":"Nrf2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol"},{"key":"B357","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2011.06.001","article-title":"Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in Pc12 cells","volume":"25","author":"Um","year":"2011","journal-title":"Nitric Oxide"},{"key":"B358","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41419-025-07883-8","article-title":"Hif-1\u03b1 alleviates ferroptosis in ulcerative colitis by regulation of Gpx4","volume":"16","author":"Hu","year":"2025","journal-title":"Cell Death Dis"},{"key":"B359","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1513433112","article-title":"Chemotherapy triggers Hif-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype","volume":"112","author":"Lu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B360","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.995047","article-title":"Glutathione peroxidase 4 (Gpx4) and ferroptosis: What's so special about it","volume":"2","author":"Conrad","year":"2015","journal-title":"Mol Cell Oncol"},{"key":"B361","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s40478-023-01617-7","article-title":"Ferroptosis induces detrimental effects in chronic Eae and its implications for progressive Ms","volume":"11","author":"Jhelum","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"B362","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577995","article-title":"Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis","volume":"373","author":"Li","year":"2022","journal-title":"J Neuroimmunol"},{"key":"B363","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00883-0","article-title":"Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis","volume":"19","author":"Luoqian","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B364","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.742483","article-title":"Fundamental mechanisms of the cell death caused by nitrosative stress","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B365","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120257","article-title":"The emerging roles of nitric oxide in ferroptosis and pyroptosis of tumor cells","volume":"290","author":"He","year":"2022","journal-title":"Life Sci"},{"key":"B366","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.niox.2021.07.003","article-title":"Nitric oxide protects against ferroptosis by aborting the lipid peroxidation chain reaction","volume":"115","author":"Homma","year":"2021","journal-title":"Nitric Oxide"},{"key":"B367","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102045","article-title":"A new thiol-independent mechanism of epithelial host defense against Pseudomonas aeruginosa: Inos\/No(\u2022) sabotage of theft-ferroptosis","volume":"45","author":"Dar","year":"2021","journal-title":"Redox Biol"},{"key":"B368","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1016\/j.apsb.2023.07.010","article-title":"Oxidative stress, the blood-brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants","volume":"13","author":"Feng","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B369","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2015.02.016","article-title":"Inorganic nitrite attenuates Nadph oxidase-derived superoxide generation in activated macrophages via a nitric oxide-dependent mechanism","volume":"83","author":"Yang","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"B370","doi-asserted-by":"publisher","first-page":"19","DOI":"10.17712\/1658-3183.1242","article-title":"Oxidative stress and neurodegenerative disease","volume":"9","author":"Al-Ayadhi","year":"2004","journal-title":"Neurosci (Riyadh)"},{"key":"B371","doi-asserted-by":"publisher","DOI":"10.1080\/09674845.2013.11669939","article-title":"Glutathione in multiple sclerosis","volume":"70","author":"Ferreira","year":"2013","journal-title":"Br J BioMed Sci"},{"key":"B372","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.108985","article-title":"Involvement of nitric oxide synthase\/nitric oxide pathway in the regulation of Sirt1-Ampk crosstalk in podocytes: Impact on glucose uptake","volume":"709","author":"Rogacka","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"B373","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.10.809","article-title":"Dietary nitrite improves insulin signaling through Glut4 translocation","volume":"67","author":"Jiang","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"B374","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00863","article-title":"Cgmp\/Pkg-I pathway-mediated Glut1\/4 regulation by No in female rat granulosa cells","volume":"159","author":"Tian","year":"2018","journal-title":"Endocrinology"},{"key":"B375","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.102994","article-title":"Beta-cell-selective inhibition of DNA damage response signaling by nitric oxide is associated with an attenuation in glucose uptake","volume":"299","author":"Yeo","year":"2023","journal-title":"J Biol Chem"},{"key":"B376","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.2.241","article-title":"Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle","volume":"50","author":"Higaki","year":"2001","journal-title":"Diabetes"},{"key":"B377","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ncb1080","article-title":"Nitric oxide switches on glycolysis through the Amp protein kinase and 6-phosphofructo-2-kinase pathway","volume":"6","author":"Almeida","year":"2004","journal-title":"Nat Cell Biol"},{"key":"B378","doi-asserted-by":"publisher","DOI":"10.1042\/bj20040886","article-title":"Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective Glut3-mediated glucose uptake through 5'-Amp-activated protein kinase","volume":"384","author":"Cidad","year":"2004","journal-title":"Biochem J"},{"key":"B379","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/jp280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (Hif): Implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J Physiol"},{"key":"B380","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1995.269.3.C739","article-title":"S-nitrosoglutathione reversibly inhibits Gapdh by S-nitrosylation","volume":"269","author":"Padgett","year":"1995","journal-title":"Am J Physiol"},{"key":"B381","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1995.268.3.C669","article-title":"Impact of nitric oxide on macrophage glucose metabolism and glyceraldehyde-3-phosphate dehydrogenase activity","volume":"268","author":"Mateo","year":"1995","journal-title":"Am J Physiol"},{"key":"B382","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.8.4209","article-title":"Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent Nadh attachment","volume":"271","author":"Mohr","year":"1996","journal-title":"J Biol Chem"},{"key":"B383","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1268","article-title":"S-nitrosylated Gapdh initiates apoptotic cell death by nuclear translocation following Siah1 binding","volume":"7","author":"Hara","year":"2005","journal-title":"Nat Cell Biol"},{"key":"B384","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-006-9011-6","article-title":"Nitric oxide-Gapdh-Siah: A novel cell death cascade","volume":"26","author":"Hara","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"B385","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-018-07457-z","article-title":"Metabolism reprogrammed by the nitric oxide signalling molecule","volume":"565","author":"Lowenstein","year":"2019","journal-title":"Nature"},{"key":"B386","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100938","article-title":"Nitric oxide maintains endothelial redox homeostasis through Pkm2 inhibition","volume":"38","author":"Siragusa","year":"2019","journal-title":"EMBO J"},{"key":"B387","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2019.7803","article-title":"Metabolic responses to reductive stress","volume":"32","author":"Xiao","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"B388","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.10.092","article-title":"A defective pentose phosphate pathway reduces inflammatory macrophage responses during hypercholesterolemia","volume":"25","author":"Baardman","year":"2018","journal-title":"Cell Rep"},{"key":"B389","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9020140","article-title":"Glucose as a major antioxidant: When, what for and why it fails","volume":"9","author":"Cherkas","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B390","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003252","article-title":"Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation","volume":"6","author":"Doulias","year":"2013","journal-title":"Sci Signal"},{"key":"B391","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B392","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00115","article-title":"Differential regulation of human Treg and Th17 cells by fatty acid synthesis and glycolysis","volume":"10","author":"Cluxton","year":"2019","journal-title":"Front Immunol"},{"key":"B393","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053019","article-title":"Unraveling the complex interplay between T cell metabolism and function","volume":"36","author":"Geltink","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B394","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B395","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2011.12.012","article-title":"A nonclinical safety and pharmacokinetic evaluation of N6022: A first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma","volume":"62","author":"Colagiovanni","year":"2012","journal-title":"Regul Toxicol Pharmacol"},{"key":"B396","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"B397","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N Engl J Med"},{"key":"B398","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000012700","article-title":"Safety of ocrelizumab in patients with relapsing and primary progressive multiple sclerosis","volume":"97","author":"Hauser","year":"2021","journal-title":"Neurology"},{"key":"B399","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231195346","article-title":"Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The Alithios open-label extension","volume":"29","author":"Hauser","year":"2023","journal-title":"Mult Scler"},{"key":"B400","doi-asserted-by":"publisher","DOI":"10.1177\/20552173251414528","article-title":"Real-world safety and effectiveness of ofatumumab in multiple sclerosis: A clinic-based study in Australia","volume":"12","author":"Montague","year":"2026","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B401","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"B402","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"B403","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double-blind placebo-controlled study of interferon \u03b2-1a in relapsing\/remitting multiple sclerosis","volume":"352","author":"Ebers","year":"1998","journal-title":"Lancet"},{"key":"B404","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535cf6","article-title":"Survival in ms: a randomized cohort study 21 years after the start of the pivotal ifn\u03b2-1b trial","volume":"78","author":"Goodin","year":"2012","journal-title":"Neurology"},{"key":"B405","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.1040768","article-title":"Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis","volume":"15","author":"Boster","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"B406","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.45.7.1268","article-title":"Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase iii multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group","volume":"45","author":"Johnson","year":"1995","journal-title":"Neurology"},{"key":"B407","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23938","article-title":"Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis","volume":"73","author":"Khan","year":"2013","journal-title":"Ann Neurol"},{"key":"B408","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.9.3.319","article-title":"Why did il-12\/il-23 antibody therapy fail in multiple sclerosis","volume":"9","author":"Longbrake","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"B409","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N Engl J Med"},{"key":"B410","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052643","article-title":"Oral fingolimod (fty720) for relapsing multiple sclerosis","volume":"355","author":"Kappos","year":"2006","journal-title":"N Engl J Med"},{"key":"B411","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0826","article-title":"Rebound syndrome in patients with multiple sclerosis after cessation of fingolimod treatment","volume":"73","author":"Hatcher","year":"2016","journal-title":"JAMA Neurol"},{"key":"B412","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral bg-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N Engl J Med"},{"key":"B413","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420915005","article-title":"Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of define, confirm, and endorse","volume":"13","author":"Gold","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"B414","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014656","article-title":"Randomized trial of oral teriflunomide for relapsing multiple sclerosis","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"B415","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000002506","article-title":"Calming the excitement in als","volume":"86","author":"Glass","year":"2016","journal-title":"Neurology"},{"key":"B416","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-014-0020-y","article-title":"Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis","volume":"3","author":"Kieseier","year":"2014","journal-title":"Neurol Ther"},{"key":"B417","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902533","article-title":"A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis","volume":"362","author":"Giovannoni","year":"2010","journal-title":"N Engl J Med"},{"key":"B418","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517727603","article-title":"Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: results from the randomized extension trial of the clarity study","volume":"24","author":"Giovannoni","year":"2018","journal-title":"Mult Scler"},{"key":"B419","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(21)00237-4","article-title":"Safety and efficacy of tolebrutinib, an oral brain-penetrant btk inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial","volume":"20","author":"Reich","year":"2021","journal-title":"Lancet Neurol"},{"key":"B420","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41582-023-00800-7","article-title":"Bruton tyrosine kinase inhibitors for multiple sclerosis","volume":"19","author":"Kr\u00e4mer","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"B421","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(25)00174-7","article-title":"Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (fenopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study","volume":"24","author":"Bar-Or","year":"2025","journal-title":"Lancet Neurol"},{"key":"B422","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578847","article-title":"The potential role of s-nitrosoglutathione reductase in astrocyte baff expression and b cell activation in experimental autoimmune encephalomyelitis","volume":"412","author":"Won","year":"2026","journal-title":"J Neuroimmunol"},{"key":"B423","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00700-0","article-title":"Diroximel fumarate demonstrates an improved gastrointestinal tolerability profile compared with dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: results from the randomized, double-blind, phase iii evolve-ms-2 study","volume":"34","author":"Naismith","year":"2020","journal-title":"CNS Drugs"},{"key":"B424","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231205708","article-title":"Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: final safety and efficacy results from the phase 3 evolve-ms-1 study","volume":"29","author":"Singer","year":"2023","journal-title":"Mult Scler"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1797609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:32:23Z","timestamp":1787142743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1797609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":424,"alternative-id":["10.3389\/fimmu.2026.1797609"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1797609","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1797609"}}